Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN66,2566,3-0,47
Msft0,73
Nokia3,383,41750,21
IBM0,16
Mercedes-Benz Group AG71,1671,17-0,04
PFE1,91
03.05.2024 1:38:46
Indexy online
AD Index online
select
AD Index online
 

  • 02.05.2024
Avantor Rg (NY Consolidated)
Závěr k 2.5.2024 Změna (%) Změna (USD) Objem obchodů (ks)
24,32 -0,41 -0,10 4 081 961
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 03.05.2024
Popis společnosti
Obecné informace
Název společnostiAvantor Inc
TickerAVTR
Kmenové akcie:Ordinary Shares
RICAVTR.K
ISIN-
Prioritní akcieConv. Pref. Shrs Series A
RICAVTR_pa.N^E22
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.12.2023 14 500
Akcie v oběhu k 15.03.2024 679 174 353
MěnaUSD
Kontaktní informace
UliceBuilding One
MěstoRADNOR
PSČ19087
ZeměUnited States
Kontatní osobaChristina Jones
Funkce kontaktní osobyVice President, Investor Relations
Telefon16 103 861 700
Fax13026365454
Kontatní telefon18 056 175 297

Business Summary: Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Financial Summary: BRIEF: For the three months ended 31 March 2024, Avantor Inc revenues decreased 6% to $1.68B. Net income decreased 50% to $60.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Selling/General/Admin Expense increase of 8% to $424.2M (expense), Loss on extinguishment of debt increase of 9% to $2.5M (expense).
Odvětvová klasifikace
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
MGINDUSTRYScientific & Technical Instr.
MGSECTORTechnology
NAICSOther Professional Equipment and Supplies Merchant Wholesalers
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Other Professional Equipment and Supplies Merchant Wholesalers
NAICS1997Other Professional Equipment and Supplies Wholesalers
SICProfessional Equipment, Nec
SICPharmaceutical Preparations



  • Poslední aktualizace: 03.05.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorMichael Stubblefield5101.01.2014
Chief Financial Officer, Executive Vice PresidentR. Brent Jones5407.08.202307.08.2023
Executive Vice President, Sales and Customer ExcellenceJames Bramwell5701.01.2024
Executive Vice President, AMEAChristophe Couturier58
Executive Vice President, Strategy and Corporate DevelopmentKitty Sahin5419.07.202219.07.2022
Executive Vice President, Laboratory SolutionsRandy Stone5701.01.202401.01.2024